NEW YORK (GenomeWeb) – Medicinal Genomics and Courtagen have been awarded a Small Business and Innovation Research grant to develop technology to detect toxins from microbiological contamination of medical marijuana, the companies said today.

The Phase I award from the National Institute on Drug Abuse is for approximately $150,000 and will go toward developing immuno-PCR-based tests, Mike Catalano, senior director of marketing for Medicinal Genomics, said in an email.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.